Published in Ann Trop Med Parasitol on June 01, 1985
The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66
The influence of urbanisation on measures of Plasmodium falciparum infection prevalence in East Africa. Acta Trop (2005) 2.23
Plasmodium ovale: parasite and disease. Clin Microbiol Rev (2005) 2.08
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol (1994) 1.44
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
Characterization of the humoral immune response in Plasmodium falciparum malaria. III. Factors influencing the coexpression of antibody isotypes (IgM and IgG-1 to 4). Clin Exp Immunol (1986) 1.05
Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum. J Clin Microbiol (1987) 1.05
T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A (1988) 1.03
A Plasmodium falciparum antigen containing clusters of asparagine residues. Proc Natl Acad Sci U S A (1986) 0.91
Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia. Bull World Health Organ (1991) 0.88
Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas. Clin Exp Immunol (1999) 0.79
Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions. Clin Exp Immunol (1993) 0.78
Malaria eradication on islands. Lancet (2000) 3.51
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
Combining intensity, edge and shape information for 2D and 3D segmentation of cell nuclei in tissue sections. J Microsc (2004) 3.01
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg (2001) 2.34
Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol (1981) 2.03
[Tetanus with a deep wound?]. Lakartidningen (1994) 1.92
Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg (1996) 1.90
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J Infect Dis (1999) 1.81
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop (2003) 1.80
Fever episodes in a holoendemic malaria area of Tanzania: parasitological and clinical findings and diagnostic aspects related to malaria. Trans R Soc Trop Med Hyg (1993) 1.79
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Agranulocytosis associated with malaria prophylaxis with Maloprim. Br Med J (Clin Res Ed) (1983) 1.72
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health (1996) 1.65
Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol (1979) 1.65
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1992) 1.63
Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Aliment Pharmacol Ther (2005) 1.59
Predicting breast cancer recurrence. Cancer (1982) 1.57
Malaria chemoprophylaxis with mefloquine. Lancet (1991) 1.55
Characterization of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA. Clin Exp Immunol (1983) 1.54
Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol (1980) 1.53
The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications. Ann Trop Med Parasitol (1979) 1.51
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis. Bull World Health Organ (1987) 1.43
Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J (2006) 1.42
Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am J Trop Med Hyg (1986) 1.40
Five-year follow-up study of cases suggestive of acute myocarditis. Am Heart J (1966) 1.38
Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br J Clin Pharmacol (1996) 1.35
Histopathological systems of breast cancer classification: reproducibility and clinical significance. J Clin Pathol (1983) 1.34
Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. Trans R Soc Trop Med Hyg (1999) 1.34
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies. BMJ (1988) 1.34
Synergism of benflumetol and artemether in Plasmodium falciparum. Am J Trop Med Hyg (1999) 1.33
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol (1984) 1.32
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ (2003) 1.31
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J Pharm Biomed Anal (2007) 1.27
Cardiac glycosides and breast cancer, revisited. N Engl J Med (1982) 1.26
A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassaemia traits. Ann Trop Med Parasitol (1983) 1.24
A pocket of controlled malaria in a holoendemic region of West Africa. Ann Trop Med Parasitol (1979) 1.24
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (1998) 1.24
Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum. Trop Med Parasitol (1986) 1.22
Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper. Ther Drug Monit (1985) 1.21
In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1991) 1.21
Changes in erythrocyte sedimentation rate, C-reactive protein and hematological parameters in patients with acute malaria. Scand J Infect Dis (1989) 1.20
Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran. Acta Trop (2006) 1.19
Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. Acta Trop (1998) 1.19
Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol (2004) 1.18
A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp Cell Res (2000) 1.17
Cardiac glycosides and breast cancer. Lancet (1979) 1.16
Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gammadelta+ T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol (1997) 1.14
Falciparum malaria and beta-thalassaemia trait in northern Liberia. Ann Trop Med Parasitol (1983) 1.14
Long-term survival in transfusion recipients in Sweden, 1993. Transfusion (2001) 1.12
Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum. Science (1986) 1.11
High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. Pharmacogenetics (1999) 1.09
Myocarditis and cardiomyopathy. Clinical aspects. Cardiologia (1968) 1.08
Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Br Med J (Clin Res Ed) (1987) 1.08
Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro. Am J Trop Med Hyg (1992) 1.08
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol (2000) 1.06
Towards a closed eye model of the pre-ocular tear layer. Prog Retin Eye Res (2000) 1.05
Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans R Soc Trop Med Hyg (1999) 1.05
Characterization of the humoral immune response in Plasmodium falciparum malaria. III. Factors influencing the coexpression of antibody isotypes (IgM and IgG-1 to 4). Clin Exp Immunol (1986) 1.05
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
Acute psychosis following mefloquine prophylaxis. Lancet (1989) 1.05
Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS (1999) 1.05
In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother (2002) 1.04
Higher proportion of CD8+ T cells in the blood in healthy adults from Ethiopia and Bangladesh compared with Sweden. Trans R Soc Trop Med Hyg (1998) 1.04
pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine. Antimicrob Agents Chemother (2012) 1.04
T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A (1988) 1.03
Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res (1978) 1.03
Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ (1989) 1.03
In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum. Br J Clin Pharmacol (1986) 1.03
Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1981) 1.02
Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid. J Infect Dis (1979) 1.01
Principal component analysis of dynamic positron emission tomography images. Eur J Nucl Med (1994) 1.01
Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene Pfmdr1. Trans R Soc Trop Med Hyg (1996) 1.01
Sulfadoxine assay using capillary blood samples dried on filter paper--suitable for monitoring of blood concentrations in the field. Ther Drug Monit (1987) 1.00
Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res (2001) 1.00
Painless venepuncture in the field. Trans R Soc Trop Med Hyg (1991) 1.00
Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. Trans R Soc Trop Med Hyg (1992) 1.00
Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics. Trop Med Int Health (1997) 0.99
Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg (1991) 0.98
Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments. J Clin Microbiol (1998) 0.98
Evaluation of three qualitative tests for detection of chloroquine in urine--agreement with plasma concentrations determined with liquid chromatography. Ann Trop Med Parasitol (1986) 0.98